PTIX - צמיחת הכנסות שנתית ב-12 החודשים האחרונים Protagenic Therapeutics

Optimized raw material sourcing ensures the continuity of Protagenic Therapeutics (PTIX) clinical trials. Management is focused on developing peptide-based therapies for depression and stress. The year-over-year sales growth rate over the trailing four quarters visualizes revenue dynamics, where 0.00 determines this parameter level. A strategic alliance with synthetic peptide research centers enhances the company's attractiveness for M&A transactions, as confirmed by this chart.
Protagenic Therapeutics (PTIX) - פילוחי מדדים ודוחות פיננסיים

This indicator measures the percentage change in revenue over the last four quarters relative to the same period last year, neutralizing seasonality to assess the real pace of business expansion. By analyzing year-over-year sales dynamics over the last four quarters, an investor can see the operational efficiency of Protagenic Therapeutics (PTIX), where steady leadership and conservative capital management smooth out the volatility of this metric.